Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01956513

Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

Etude ADC Apport de l'IRM Dans l'évaluation du Coefficient de Diffusion Apparent et prédiction de la réponse à la chimiothérapie néoadjuvante Dans le Cancer du Sein

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Centre Jean Perrin · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to assess the sensitivity and the specificity of the variation of apparent diffusion coefficient for prediction, after a course of neoadjuvant chemotherapy or after modification of the treatment sequence, the pathological response at the end of chemotherapy

Conditions

Interventions

TypeNameDescription
OTHERMRI (Magnetic resonance imaging)MRI will be realised at the beginning of the study, after a cycle of chemotherapy or at changement of sequence and at the end of chemotherapy.

Timeline

Start date
2012-03-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2013-10-08
Last updated
2013-10-08

Source: ClinicalTrials.gov record NCT01956513. Inclusion in this directory is not an endorsement.